New shot could simplify breast cancer treatment before surgery
Disease control
Recruiting now
This study tests a drug called Phesgo, given as a shot under the skin, for women with early-stage HER2-positive breast cancer before they have surgery. About 70 women in Algeria will receive Phesgo along with standard chemotherapy for about 18 weeks. The main goal is to see how m…
Sponsor: Blida 1 University • Aim: Disease control
Last updated Jun 26, 2026 15:29 UTC